Concepts (191)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Oxidative Stress | 25 | 2023 | 803 | 4.530 |
Why?
|
| Receptors, Dopamine D1 | 17 | 2019 | 85 | 4.260 |
Why?
|
| Kidney | 20 | 2023 | 1358 | 3.220 |
Why?
|
| Kidney Tubules, Proximal | 14 | 2020 | 109 | 2.920 |
Why?
|
| Hypertension | 14 | 2020 | 1323 | 2.710 |
Why?
|
| Antioxidants | 14 | 2023 | 335 | 2.590 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 14 | 2019 | 102 | 2.080 |
Why?
|
| NF-E2-Related Factor 2 | 5 | 2022 | 113 | 2.000 |
Why?
|
| Angiotensin I | 3 | 2023 | 10 | 1.720 |
Why?
|
| Receptor, Angiotensin, Type 1 | 6 | 2014 | 61 | 1.700 |
Why?
|
| Natriuresis | 6 | 2019 | 37 | 1.480 |
Why?
|
| Buthionine Sulfoximine | 9 | 2020 | 28 | 1.430 |
Why?
|
| Rats | 28 | 2022 | 3675 | 1.380 |
Why?
|
| Peptide Fragments | 3 | 2023 | 779 | 1.290 |
Why?
|
| Protein Kinase C | 7 | 2016 | 149 | 1.290 |
Why?
|
| Blood Pressure | 10 | 2020 | 1352 | 1.260 |
Why?
|
| Dopamine | 6 | 2019 | 282 | 1.160 |
Why?
|
| Insulin | 8 | 2016 | 1203 | 1.150 |
Why?
|
| Sodium-Hydrogen Exchangers | 6 | 2019 | 40 | 1.120 |
Why?
|
| Rats, Sprague-Dawley | 16 | 2019 | 1231 | 1.120 |
Why?
|
| Angiotensin II | 4 | 2023 | 164 | 1.110 |
Why?
|
| Sodium Chloride, Dietary | 3 | 2019 | 38 | 1.010 |
Why?
|
| Nitric Oxide | 5 | 2018 | 445 | 0.920 |
Why?
|
| 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 10 | 2019 | 39 | 0.870 |
Why?
|
| Cyclic N-Oxides | 7 | 2020 | 30 | 0.860 |
Why?
|
| Reactive Oxygen Species | 3 | 2023 | 484 | 0.860 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 3 | 2019 | 14 | 0.840 |
Why?
|
| Reperfusion Injury | 2 | 2022 | 100 | 0.800 |
Why?
|
| Hypertension, Renal | 2 | 2015 | 38 | 0.780 |
Why?
|
| Mitochondrial Diseases | 1 | 2023 | 133 | 0.770 |
Why?
|
| Up-Regulation | 4 | 2014 | 862 | 0.770 |
Why?
|
| Signal Transduction | 10 | 2020 | 4493 | 0.770 |
Why?
|
| Dopamine Agonists | 9 | 2019 | 79 | 0.750 |
Why?
|
| Diuresis | 4 | 2019 | 58 | 0.730 |
Why?
|
| Sodium | 4 | 2019 | 295 | 0.720 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2020 | 28 | 0.700 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2016 | 336 | 0.700 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2020 | 37 | 0.700 |
Why?
|
| beta-Adrenergic Receptor Kinases | 4 | 2007 | 26 | 0.690 |
Why?
|
| Spin Labels | 7 | 2020 | 39 | 0.680 |
Why?
|
| NF-kappa B | 3 | 2014 | 455 | 0.680 |
Why?
|
| Animals | 35 | 2022 | 34025 | 0.680 |
Why?
|
| Nephritis | 1 | 2019 | 20 | 0.670 |
Why?
|
| Hyperinsulinism | 4 | 2010 | 67 | 0.640 |
Why?
|
| Hypoglycemic Agents | 4 | 2016 | 443 | 0.640 |
Why?
|
| Mitochondria | 2 | 2020 | 681 | 0.610 |
Why?
|
| Mesenteric Arteries | 1 | 2018 | 57 | 0.570 |
Why?
|
| Apoptosis | 2 | 2023 | 1790 | 0.570 |
Why?
|
| Oxidants | 4 | 2014 | 25 | 0.570 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2019 | 292 | 0.540 |
Why?
|
| Cell Adhesion Molecules | 1 | 2018 | 221 | 0.530 |
Why?
|
| Epithelial Cells | 2 | 2020 | 909 | 0.510 |
Why?
|
| Microfilament Proteins | 1 | 2018 | 273 | 0.510 |
Why?
|
| Phosphoproteins | 1 | 2018 | 401 | 0.500 |
Why?
|
| MicroRNAs | 1 | 2022 | 835 | 0.480 |
Why?
|
| Stilbenes | 2 | 2015 | 36 | 0.480 |
Why?
|
| Acute Kidney Injury | 1 | 2022 | 636 | 0.470 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2014 | 238 | 0.460 |
Why?
|
| Phosphorylation | 7 | 2018 | 1614 | 0.450 |
Why?
|
| Type C Phospholipases | 3 | 2011 | 28 | 0.450 |
Why?
|
| Gastrins | 1 | 2013 | 33 | 0.430 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2011 | 219 | 0.420 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2008 | 206 | 0.390 |
Why?
|
| Vasodilation | 2 | 2018 | 190 | 0.390 |
Why?
|
| Obesity | 5 | 2007 | 2245 | 0.380 |
Why?
|
| Microvilli | 3 | 2008 | 71 | 0.380 |
Why?
|
| Sodium-Hydrogen Exchanger 3 | 4 | 2013 | 12 | 0.370 |
Why?
|
| Carbohydrate Metabolism | 2 | 2008 | 56 | 0.360 |
Why?
|
| Rats, Zucker | 6 | 2010 | 41 | 0.360 |
Why?
|
| Male | 25 | 2022 | 61270 | 0.360 |
Why?
|
| Serine | 4 | 2018 | 173 | 0.350 |
Why?
|
| GTP-Binding Proteins | 3 | 2007 | 177 | 0.350 |
Why?
|
| RNA, Messenger | 2 | 2015 | 2814 | 0.340 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 1697 | 0.320 |
Why?
|
| Physical Conditioning, Animal | 1 | 2010 | 97 | 0.320 |
Why?
|
| Receptors, Dopamine | 1 | 2008 | 40 | 0.300 |
Why?
|
| Uranyl Nitrate | 1 | 2008 | 3 | 0.300 |
Why?
|
| Cell Line | 4 | 2020 | 2746 | 0.290 |
Why?
|
| Vasoconstrictor Agents | 1 | 2008 | 136 | 0.290 |
Why?
|
| Sodium Chloride | 1 | 2007 | 94 | 0.280 |
Why?
|
| Gentamicins | 1 | 2007 | 95 | 0.280 |
Why?
|
| Dopamine Antagonists | 3 | 2019 | 50 | 0.280 |
Why?
|
| Enzyme Activation | 4 | 2011 | 622 | 0.280 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2007 | 19 | 0.280 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2006 | 17 | 0.270 |
Why?
|
| Enzyme Inhibitors | 4 | 2020 | 579 | 0.270 |
Why?
|
| Hydrogen Peroxide | 2 | 2023 | 112 | 0.270 |
Why?
|
| Opossums | 3 | 2016 | 12 | 0.270 |
Why?
|
| Malondialdehyde | 4 | 2011 | 35 | 0.240 |
Why?
|
| Rats, Inbred SHR | 3 | 2015 | 65 | 0.230 |
Why?
|
| Benzazepines | 3 | 2019 | 62 | 0.220 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 5 | 2007 | 29 | 0.220 |
Why?
|
| Endothelial Cells | 1 | 2007 | 521 | 0.210 |
Why?
|
| Gene Expression Regulation | 3 | 2020 | 2520 | 0.200 |
Why?
|
| Disease Models, Animal | 5 | 2015 | 4342 | 0.180 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2023 | 430 | 0.180 |
Why?
|
| Inflammation | 2 | 2020 | 1431 | 0.180 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2020 | 117 | 0.170 |
Why?
|
| Ischemia | 2 | 2022 | 357 | 0.170 |
Why?
|
| Eating | 3 | 2015 | 368 | 0.170 |
Why?
|
| Cell Membrane | 3 | 2007 | 461 | 0.160 |
Why?
|
| G-Protein-Coupled Receptor Kinase 2 | 3 | 2007 | 15 | 0.160 |
Why?
|
| Oxidation-Reduction | 1 | 2019 | 441 | 0.150 |
Why?
|
| RNA Interference | 1 | 2020 | 497 | 0.150 |
Why?
|
| TRPC Cation Channels | 1 | 2018 | 21 | 0.150 |
Why?
|
| Lysosomes | 1 | 2019 | 236 | 0.150 |
Why?
|
| Body Weight | 3 | 2015 | 990 | 0.140 |
Why?
|
| Blood Glucose | 4 | 2006 | 1136 | 0.140 |
Why?
|
| Protein Transport | 2 | 2010 | 368 | 0.140 |
Why?
|
| Rats, Inbred WKY | 2 | 2015 | 53 | 0.140 |
Why?
|
| Adenylyl Cyclases | 2 | 2007 | 83 | 0.140 |
Why?
|
| Alkaline Phosphatase | 2 | 2007 | 97 | 0.140 |
Why?
|
| Thioctic Acid | 2 | 2007 | 12 | 0.140 |
Why?
|
| Aorta | 2 | 2014 | 541 | 0.140 |
Why?
|
| Proline | 2 | 2014 | 78 | 0.120 |
Why?
|
| Drinking | 2 | 2015 | 34 | 0.120 |
Why?
|
| Energy Metabolism | 1 | 2020 | 767 | 0.120 |
Why?
|
| Thiocarbamates | 1 | 2014 | 5 | 0.110 |
Why?
|
| Thiocyanates | 1 | 2013 | 10 | 0.110 |
Why?
|
| Sulfoxides | 1 | 2013 | 10 | 0.110 |
Why?
|
| Isothiocyanates | 1 | 2013 | 13 | 0.110 |
Why?
|
| Cells, Cultured | 2 | 2014 | 3038 | 0.110 |
Why?
|
| Vasoconstriction | 1 | 2014 | 101 | 0.110 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 822 | 0.100 |
Why?
|
| Calcium | 1 | 2018 | 1099 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 4375 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 1586 | 0.090 |
Why?
|
| Radioimmunoassay | 1 | 2011 | 107 | 0.090 |
Why?
|
| Tyrosine | 1 | 2011 | 150 | 0.090 |
Why?
|
| Kidney Cortex | 2 | 2008 | 20 | 0.090 |
Why?
|
| Albuminuria | 1 | 2010 | 99 | 0.080 |
Why?
|
| Organ Size | 1 | 2011 | 425 | 0.080 |
Why?
|
| Janus Kinase 2 | 1 | 2011 | 132 | 0.080 |
Why?
|
| Rats, Wistar | 2 | 2007 | 359 | 0.080 |
Why?
|
| Amidohydrolases | 1 | 2009 | 23 | 0.080 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2008 | 7 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2011 | 1016 | 0.080 |
Why?
|
| Humans | 5 | 2023 | 124728 | 0.080 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 2008 | 13 | 0.080 |
Why?
|
| Biphenyl Compounds | 1 | 2008 | 56 | 0.080 |
Why?
|
| Cyclic GMP | 1 | 2008 | 94 | 0.070 |
Why?
|
| Tetrazoles | 1 | 2008 | 68 | 0.070 |
Why?
|
| Glycosuria | 1 | 2008 | 6 | 0.070 |
Why?
|
| Endothelium, Vascular | 1 | 2011 | 520 | 0.070 |
Why?
|
| Membranes | 1 | 2007 | 23 | 0.070 |
Why?
|
| Urodynamics | 1 | 2008 | 40 | 0.070 |
Why?
|
| Glutathione Peroxidase | 1 | 2007 | 31 | 0.070 |
Why?
|
| Electrolytes | 1 | 2008 | 52 | 0.070 |
Why?
|
| Injections, Intraperitoneal | 1 | 2007 | 73 | 0.070 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2007 | 47 | 0.070 |
Why?
|
| Catalase | 1 | 2007 | 50 | 0.070 |
Why?
|
| Enzymes | 1 | 2008 | 52 | 0.070 |
Why?
|
| Benzimidazoles | 1 | 2008 | 132 | 0.070 |
Why?
|
| Blotting, Western | 2 | 2007 | 1101 | 0.070 |
Why?
|
| Lipid Peroxidation | 1 | 2007 | 88 | 0.070 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 1 | 2007 | 13 | 0.070 |
Why?
|
| Superoxide Dismutase | 1 | 2007 | 137 | 0.070 |
Why?
|
| Cardiotonic Agents | 1 | 2008 | 138 | 0.070 |
Why?
|
| Arginine | 1 | 2009 | 332 | 0.070 |
Why?
|
| Potassium | 1 | 2007 | 280 | 0.070 |
Why?
|
| MAP Kinase Signaling System | 1 | 2008 | 310 | 0.070 |
Why?
|
| Heart | 1 | 2011 | 710 | 0.070 |
Why?
|
| Immunoprecipitation | 1 | 2006 | 198 | 0.070 |
Why?
|
| Cyclic AMP | 1 | 2006 | 246 | 0.060 |
Why?
|
| Antihypertensive Agents | 1 | 2008 | 412 | 0.060 |
Why?
|
| Phosphates | 1 | 2005 | 113 | 0.060 |
Why?
|
| Mice | 1 | 2020 | 17577 | 0.050 |
Why?
|
| Ligands | 1 | 2005 | 532 | 0.050 |
Why?
|
| Kidney Diseases | 1 | 2007 | 481 | 0.050 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2003 | 137 | 0.050 |
Why?
|
| Thiazoles | 1 | 2002 | 98 | 0.050 |
Why?
|
| Thiazolidinediones | 1 | 2002 | 82 | 0.050 |
Why?
|
| Models, Biological | 1 | 2007 | 1458 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2007 | 1111 | 0.040 |
Why?
|
| Time Factors | 2 | 2007 | 6308 | 0.040 |
Why?
|
| Gene Expression | 1 | 2005 | 1560 | 0.040 |
Why?
|
| Diet | 1 | 2007 | 1138 | 0.040 |
Why?
|
| Biomarkers | 1 | 2007 | 3067 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2007 | 2428 | 0.030 |
Why?
|
| Reperfusion | 1 | 2005 | 25 | 0.020 |
Why?
|
| Phorbol Esters | 1 | 2005 | 22 | 0.020 |
Why?
|
| Triiodothyronine | 1 | 2005 | 62 | 0.020 |
Why?
|
| Phosphorus | 1 | 2005 | 56 | 0.020 |
Why?
|
| Thyroid Hormones | 1 | 2005 | 67 | 0.020 |
Why?
|
| Biological Transport | 1 | 2005 | 354 | 0.010 |
Why?
|
| Kinetics | 1 | 2005 | 1323 | 0.010 |
Why?
|
| Renal Insufficiency | 1 | 2005 | 236 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2002 | 185 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2002 | 699 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 1688 | 0.010 |
Why?
|
| Glucose | 1 | 2002 | 875 | 0.010 |
Why?
|